"Voriconazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A triazole antifungal agent that specifically inhibits STEROL 14-ALPHA-DEMETHYLASE and CYTOCHROME P-450 CYP3A.
| Descriptor ID |
D065819
|
| MeSH Number(s) |
D03.383.129.799.950
|
| Concept/Terms |
UK 109,496- UK 109,496
- UK-109,496
- UK109,496
- UK-109496
- UK109496
- UK 109496
|
Below are MeSH descriptors whose meaning is more general than "Voriconazole".
Below are MeSH descriptors whose meaning is more specific than "Voriconazole".
This graph shows the total number of publications written about "Voriconazole" by people in this website by year, and whether "Voriconazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 2 | 2 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2010 | 0 | 4 | 4 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 2 | 2 | 4 |
| 2014 | 1 | 2 | 3 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Voriconazole" by people in Profiles.
-
Rahman FU, Irfan M, Fasih N, Jabeen K, Sharif H. Pulmonary scedosporiosis mimicking aspergilloma in an immunocompetent host: a case report and review of the literature. Infection. 2016 Feb; 44(1):127-32.
-
Silva RA, Sridhar J, Miller D, Wykoff CC, Flynn HW. Exogenous fungal endophthalmitis: an analysis of isolates and susceptibilities to antifungal agents over a 20-year period (1990-2010). Am J Ophthalmol. 2015 Feb; 159(2):257-64.e1.
-
Peksa GD, Schultz K, Fung HC. Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation. J Oncol Pharm Pract. 2015 Dec; 21(6):409-15.
-
Hicks JK, Crews KR, Flynn P, Haidar CE, Daniels CC, Yang W, Panetta JC, Pei D, Scott JR, Molinelli AR, Broeckel U, Bhojwani D, Evans WE, Relling MV. Voriconazole plasma concentrations in immunocompromised pediatric patients vary by CYP2C19 diplotypes. Pharmacogenomics. 2014 Jun; 15(8):1065-78.
-
Maron GM, Hayden RT, Rodriguez A, Rubnitz JE, Flynn PM, Shenep JL, Knapp KM. Voriconazole prophylaxis in children with cancer: changing outcomes and epidemiology of fungal infections. Pediatr Infect Dis J. 2013 Dec; 32(12):e451-5.
-
Vijayvargiya P, Javed I, Moreno J, Mynt MA, Kotapka M, Zaki R, Ortiz J. Pituitary aspergillosis in a kidney transplant recipient and review of the literature. Transpl Infect Dis. 2013 Oct; 15(5):E196-200.
-
Reed DC, Shah KH, Hubschman JP. Resolution of Coccidioides immitis endophthalmitis with an aggressive surgical and medical therapeutic approach. Semin Ophthalmol. 2013 Jul; 28(4):251-2.
-
Kulkarni MM, Reddy N, Gude T, McGwire BS. Voriconazole suppresses the growth of Leishmania species in vitro. Parasitol Res. 2013 May; 112(5):2095-9.
-
Hornbeek H, Ackerman BH, Reigart CL, Stair-Buchmann M, Guilday RE, Patton ML, Haith LR. Pseudallescheria boydii infection of the brain. Surg Infect (Larchmt). 2012 Jun; 13(3):179-80.
-
Katragkou A, Roilides E. Best practice in treating infants and children with proven, probable or suspected invasive fungal infections. Curr Opin Infect Dis. 2011 Jun; 24(3):225-9.